Clinical Trials Browser

Phase EARLY_PHASE1 × Endometrial Neoplasms × olaparib × Clear all

NCT05320757 2025-06-11

Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients

Phase EARLY_PHASE1 Completed

Endometrial Neoplasms